193 related articles for article (PubMed ID: 9686552)
1. Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group.
Ron E; Doody MM; Becker DV; Brill AB; Curtis RE; Goldman MB; Harris BS; Hoffman DA; McConahey WM; Maxon HR; Preston-Martin S; Warshauer ME; Wong FL; Boice JD
JAMA; 1998 Jul 22-29; 280(4):347-55. PubMed ID: 9686552
[TBL] [Abstract][Full Text] [Related]
2. Association of Radioactive Iodine, Antithyroid Drug, and Surgical Treatments With Solid Cancer Mortality in Patients With Hyperthyroidism.
Kitahara CM; Preston DL; Sosa JA; Berrington de Gonzalez A
JAMA Netw Open; 2020 Jul; 3(7):e209660. PubMed ID: 32701159
[TBL] [Abstract][Full Text] [Related]
3. Cancer mortality in women with thyroid disease.
Goldman MB; Monson RR; Maloof F
Cancer Res; 1990 Apr; 50(8):2283-9. PubMed ID: 2317816
[TBL] [Abstract][Full Text] [Related]
4. Thyroid function and mortality in patients treated for hyperthyroidism.
Franklyn JA; Sheppard MC; Maisonneuve P
JAMA; 2005 Jul; 294(1):71-80. PubMed ID: 15998893
[TBL] [Abstract][Full Text] [Related]
5. Long-term comparative cancer mortality after use of radio-iodine in the treatment of hyperthyroidism, a fully reported multicenter study.
Singer RB
J Insur Med; 2001; 33(2):138-42. PubMed ID: 11510511
[TBL] [Abstract][Full Text] [Related]
6. Radioactive iodine therapy and breast cancer. A follow-up study of hyperthyroid women.
Goldman MB; Maloof F; Monson RR; Aschengrau A; Cooper DS; Ridgway EC
Am J Epidemiol; 1988 May; 127(5):969-80. PubMed ID: 3358416
[TBL] [Abstract][Full Text] [Related]
7. Cancer mortality after iodine-131 therapy for hyperthyroidism.
Hall P; Berg G; Bjelkengren G; Boice JD; Ericsson UB; Hallquist A; Lidberg M; Lundell G; Tennvall J; Wiklund K
Int J Cancer; 1992 Apr; 50(6):886-90. PubMed ID: 1555888
[TBL] [Abstract][Full Text] [Related]
8. Comparison of mortality in hyperthyroidism during periods of treatment with thionamides and after radioiodine.
Boelaert K; Maisonneuve P; Torlinska B; Franklyn JA
J Clin Endocrinol Metab; 2013 May; 98(5):1869-82. PubMed ID: 23543662
[TBL] [Abstract][Full Text] [Related]
9. Cancer Risk After Radioactive Iodine Treatment for Hyperthyroidism: A Systematic Review and Meta-analysis.
Shim SR; Kitahara CM; Cha ES; Kim SJ; Bang YJ; Lee WJ
JAMA Netw Open; 2021 Sep; 4(9):e2125072. PubMed ID: 34533571
[TBL] [Abstract][Full Text] [Related]
10. Cancer Incidence and Mortality in Patients Treated Either With RAI or Thyroidectomy for Hyperthyroidism.
Ryödi E; Metso S; Jaatinen P; Huhtala H; Saaristo R; Välimäki M; Auvinen A
J Clin Endocrinol Metab; 2015 Oct; 100(10):3710-7. PubMed ID: 26262435
[TBL] [Abstract][Full Text] [Related]
11. Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study.
Franklyn JA; Maisonneuve P; Sheppard M; Betteridge J; Boyle P
Lancet; 1999 Jun; 353(9170):2111-5. PubMed ID: 10382695
[TBL] [Abstract][Full Text] [Related]
12. Associating radioiodine therapy in hyperthyroidism with cancer mortality: robust or random results of a statistical analysis?
Iakovou I; Giannoula E; Chatzipavlidou V; Sachpekidis C
Hell J Nucl Med; 2020; 23(1):94-95. PubMed ID: 32361719
[TBL] [Abstract][Full Text] [Related]
13. Does Radioactive Iodine Therapy for Hyperthyroidism Cause Cancer?
Kim BW
J Clin Endocrinol Metab; 2022 Jan; 107(2):e448-e457. PubMed ID: 34555150
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular Morbidity and Mortality After Treatment of Hyperthyroidism with Either Radioactive Iodine or Thyroidectomy.
Ryödi E; Metso S; Huhtala H; Välimäki M; Auvinen A; Jaatinen P
Thyroid; 2018 Sep; 28(9):1111-1120. PubMed ID: 29882483
[TBL] [Abstract][Full Text] [Related]
15. Mortality after the treatment of hyperthyroidism with radioactive iodine.
Franklyn JA; Maisonneuve P; Sheppard MC; Betteridge J; Boyle P
N Engl J Med; 1998 Mar; 338(11):712-8. PubMed ID: 9494147
[TBL] [Abstract][Full Text] [Related]
16. Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Auvinen A; Oksala H; Salmi J
J Clin Endocrinol Metab; 2007 Jun; 92(6):2190-6. PubMed ID: 17374710
[TBL] [Abstract][Full Text] [Related]
17. Association of Radioactive Iodine Treatment With Cancer Mortality in Patients With Hyperthyroidism.
Kitahara CM; Berrington de Gonzalez A; Bouville A; Brill AB; Doody MM; Melo DR; Simon SL; Sosa JA; Tulchinsky M; Villoing D; Preston DL
JAMA Intern Med; 2019 Aug; 179(8):1034-1042. PubMed ID: 31260066
[TBL] [Abstract][Full Text] [Related]
18. Increased Cardiovascular Mortality and Morbidity in Patients Treated for Toxic Nodular Goiter Compared to Graves' Disease and Nontoxic Goiter.
Giesecke P; Rosenqvist M; Frykman V; Friberg L; Wallin G; Höijer J; Lönn S; Törring O
Thyroid; 2017 Jul; 27(7):878-885. PubMed ID: 28471268
[TBL] [Abstract][Full Text] [Related]
19. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.
Alexander EK; Larsen PR
J Clin Endocrinol Metab; 2002 Mar; 87(3):1073-7. PubMed ID: 11889166
[TBL] [Abstract][Full Text] [Related]
20. Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy.
Nygaard B; Faber J; Veje A; Hegedüs L; Hansen JM
Thyroid; 1999 May; 9(5):477-81. PubMed ID: 10365679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
